Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Remission Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study
Crossref DOI link: https://doi.org/10.1007/s12325-016-0304-y
Published Online: 2016-02-23
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Jing
Yuan, Yaozong
Funding for this research was provided by:
Tillotts Pharma AG (2, 2)
Text and Data Mining valid from 2016-02-23